china biologic products inc
(CBPO:Consolidated Issue Listed on NASDAQ Global Select )
Independent Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee,China Biologic Products, Inc.
|Age||Total Calculated Compensation||This person is connected to 19 board members in 3 different organizations across 9 different industries.|
See Board Relationships
Dr. Lu Yun Gang, also known as Ken, is the Founder of APAC Capital Advisors Limited and served as Managing Director from May 2004 to July 2009. Dr. Yungang served as the Managing Director of Seres Asset Management Limited, an investment manager based in Hong Kong, since August 2009. He served as a Vice President and Chief Technology Officer of Linktone Ltd. Prior to founding APAC Capital Group, from April 1998 to May 2004, he was an equity research analyst with Credit ...
Jialong International TowerPhone: 86 10 6598 3111
Beijing, -- 100125
Board Members Memberships*
Independent Director, Member of Audit Committee, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
Independent Non-Executive Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee, Member of Compensation Committee and Member of Special Committee
Independent Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee
University of California-Los Angeles
Brigham Young University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|Linda F. Powers J.D.||Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer|
Northwest Biotherapeutics, Inc.
|Neil K. Warma||Chief Executive Officer, President and Director|
Opexa Therapeutics, Inc.
|Kang An||Chairman and General Manager|
Hualan Biological Engineering Inc.
|Hoang Kieu||Chief Executive Officer and President|
Shanghai RAAS Blood Products Co., Ltd.
|--||Compensation as of Fiscal Year 2014.|